Home > Insider Trading > Filing (0001593968-21-002045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801993	C. Sean Flynn	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139	Vp, General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-27	7,200	$16.25	9,619	No	4	M	Direct
Common Stock	Disposition	2021-08-27	7,200	$55.11	2,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-08-27	7,200	$0.00	7,200	$16.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
130,000		2029-11-04	No	4	M	Direct

Footnotes

These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.
These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.